Holdings (Monthly)
Guide ↗
Select Biotechnology Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC | 501147102 | Feb 2026 | 1,802,622 | -3,900 | $557.1M | +11.9% | 10.58% | EC |
| 2 | ABBVIE INC | 00287Y109 | Feb 2026 | 2,230,183 | -819,249 | $485.6M | -31.4% | 9.22% | EC |
| 3 | AMGEN INC | 031162100 | Feb 2026 | 1,020,981 | -128,570 | $343.9M | -22.9% | 6.53% | EC |
| 4 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 1,886,298 | -1,263,654 | $253.6M | -46.0% | 4.82% | EC |
| 5 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Feb 2026 | 371,429 | -19,071 | $130.0M | -1.1% | 2.47% | EC |
| 6 | ARGENX SE | 04016X101 | Feb 2026 | 141,444 | -7,900 | $118.2M | +3.2% | 2.25% | EC |
| 7 | COGENT BIOSCIENCES INC | 19240Q201 | Feb 2026 | 1,604,794 | -86,600 | $56.1M | -14.6% | 1.07% | EC |
| 8 | ARRIVENT BIOPHARMA INC | 04272N102 | Feb 2026 | 1,439,803 | -240,200 | $43.6M | +12.9% | 0.83% | EC |
| 9 | CANDEL THERAPEUTICS INC | 137404109 | Feb 2026 | 4,864,753 | -1,047,198 | $40.4M | +30.1% | 0.77% | EC |
| 10 | DIANTHUS THERAPEUTICS INC | 252828108 | Feb 2026 | 420,518 | -11,700 | $39.1M | +64.0% | 0.74% | EC |
| 11 | CORCEPT THERAPEUTICS INC | 218352102 | Feb 2026 | 506,746 | -68,900 | $35.2M | +71.4% | 0.67% | EC |
| 12 | CYTOKINETICS INC | 23282W605 | Feb 2026 | 449,175 | -54,000 | $34.5M | +10.1% | 0.65% | EC |
| 13 | ABIVAX SA | 00370M103 | Feb 2026 | 255,300 | -46,300 | $33.9M | -7.4% | 0.64% | EC |
| 14 | DISC MEDICINE INC | 254604101 | Feb 2026 | 454,774 | -77,400 | $31.6M | -10.8% | 0.60% | EC |
| 15 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 886,871 | -39,800 | $31.5M | -17.2% | 0.60% | EC |
| 16 | EDGEWISE THERAPEUTICS INC | 28036F105 | Feb 2026 | 699,425 | -77,500 | $23.9M | +1.0% | 0.45% | EC |
| 17 | STRUCTURE THERAPEUTICS INC | 86366E106 | Feb 2026 | 542,038 | -22,400 | $21.3M | -40.0% | 0.40% | EC |
| 18 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 1,067,669 | -21,500 | $18.7M | +3.6% | 0.36% | EC |
| 19 | VOR BIOPHARMA INC | 929033207 | Feb 2026 | 1,185,725 | -350,400 | $17.8M | -25.2% | 0.34% | EC |
| 20 | RAPPORT THERAPEUTICS INC | 75383L102 | Feb 2026 | 428,273 | -43,500 | $16.9M | +23.5% | 0.32% | EC |
| 21 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 1,097,175 | -122,400 | $15.7M | -14.9% | 0.30% | EC |
| 22 | ENLIVEN THERAPEUTICS INC | 29337E102 | Feb 2026 | 340,067 | -23,200 | $13.5M | +24.8% | 0.26% | EC |
| 23 | REPLIMUNE GROUP INC | 76029N106 | Feb 2026 | 1,514,745 | -349,800 | $13.2M | -7.7% | 0.25% | EC |
| 24 | TECTONIC THERAPEUTIC INC | 878972108 | Feb 2026 | 405,389 | -37,500 | $12.6M | +21.6% | 0.24% | EC |
| 25 | MINERALYS THERAPEUTICS INC | 603170101 | Feb 2026 | 385,900 | -35,800 | $12.2M | -1.5% | 0.23% | EC |
| 26 | BEONE MEDICINES LTD | 07725L102 | Feb 2026 | 29,698 | -12,000 | $8.6M | -35.3% | 0.16% | EC |
| 27 | NUVATION BIO INC | 67080N101 | Feb 2026 | 1,758,533 | -406,400 | $8.4M | -34.3% | 0.16% | EC |
| 28 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Feb 2026 | 287,200 | -34,300 | $8.3M | -20.1% | 0.16% | EC |
| 29 | OLEMA PHARMACEUTICALS INC | 68062P106 | Feb 2026 | 628,100 | -65,000 | $8.3M | -50.6% | 0.16% | EC |
| 30 | GERON CORP | 374163103 | Feb 2026 | 5,452,212 | -1,040,300 | $6.8M | -37.5% | 0.13% | EC |
| 31 | IMMUNEERING CORP | 45254E107 | Feb 2026 | 1,095,798 | -194,900 | $6.3M | -1.8% | 0.12% | EC |
| 32 | BIONTECH SE | 09075V102 | Feb 2026 | 64,900 | -20,500 | $6.2M | -33.8% | 0.12% | EC |
| 33 | X4 PHARMACEUTICALS INC | 98420X202 | Feb 2026 | 1,428,500 | -257,200 | $6.2M | +6.2% | 0.12% | EC |
| 34 | NURIX THERAPEUTICS INC | 67080M103 | Feb 2026 | 333,346 | -63,300 | $5.9M | -6.5% | 0.11% | EC |
| 35 | AKTIS ONCOLOGY INC | 01021M104 | Feb 2026 | 283,355 | -100,600 | $5.9M | -24.0% | 0.11% | EC |
| 36 | DESIGN THERAPEUTICS INC | 25056L103 | Feb 2026 | 534,931 | -81,900 | $5.6M | -12.9% | 0.11% | EC |
| 37 | LB PHARMACEUTICALS INC | 50180M108 | Feb 2026 | 187,731 | -34,000 | $5.3M | -1.4% | 0.10% | EC |
| 38 | ALECTOR INC | 014442107 | Feb 2026 | 1,380,204 | -840,900 | $3.0M | -44.8% | 0.06% | EC |
| 39 | VERTEX PHARMACEUTICALS INC | 92532F100 | Feb 2026 | 5,106 | -107,794 | $2.3M | -95.9% | 0.04% | EC |
| 40 | FOGHORN THERAPEUTICS INC | 344174107 | Feb 2026 | 351,578 | -302,700 | $1.5M | -59.5% | 0.03% | EC |
| 41 | REGENERON PHARMACEUTICALS INC | 75886F107 | Feb 2026 | 1,000 | -100,316 | $615K | -99.2% | 0.01% | EC |